2025-04-182025-04-18https://203.71.86.71/handle/123456789/197有鑒於國內轉譯醫學研究相關領域人才，特別是具備有優勢條件從事轉譯醫學研究之 醫師科學家仍屬嚴重不足，因此本校與中央研究院籌畫共同設立轉譯醫學博士學位學程， 透過基礎及臨床教師的共同指導，幫助研究生瞭解轉譯醫學的觀念、倫理、法規、研究方 法。將臨床上所遇到的問題，藉由新穎現代的轉譯醫學研究方法得到答案。從基礎研究到 臨床試驗，即從實驗室到病患的全階段研究，探索與疾病相關的基因及其分子生物學病理 機制，並根據疾病相關的基因及其分子生物學病理機制的研究發現，研發創新的診斷或標 的治療，以解決當前醫藥開發的瓶頸。 本學程於 2011 年 6 月獲教育部核准設立，與中央研究院共同辦理轉譯醫學博士學位學 程，目前共有全國七所醫學大學（100 學年度與台灣大學及高雄醫學大學，101 學年度與陽 明大學、臺北醫學大學、中國醫藥大學，103 學年度慈濟醫學大學、國防醫學大學加入）設 置此學程。學程運作模式七校相同，由各醫學大學與中央研究院雙方推派共同總召集人， 置「執行委員會」下設「招生委員會」、「教務委員會」與「學生事務委員會」等三個委員 會，由雙方人員共同參加，並各推派若干人擔任委員會委員，必要時另聘諮詢委員會委員。 本學程於 2012 年 8 月正式招生。除聘有專任教師、亦合聘有校內外基礎研究學者、多名中 央研究院院士，講座教授參與授課及指導研究生，更聘有國內外在生技產業界具有實務經 驗之客座教授，分享及傳授其成功之經驗。Given the significant shortage of talent in the field of translational medicine research in Taiwan, particularly of physician-scientists with advantageous qualifications to conduct such research, our university has collaborated with Academia Sinica to jointly establish a PhD program in translational medicine. Through the joint guidance of both basic and clinical faculty, the program helps students understand the concepts, ethics, regulations, and research methods of translational medicine. The program aims to address clinical problems through modern and innovative translational medicine research methods, exploring gene-related diseases and their molecular pathological mechanisms, from basic research to clinical trials—essentially from the laboratory to the patient. The findings based on these studies can lead to the development of innovative diagnostics or targeted therapies, thereby overcoming current bottlenecks in medical development. This program was approved by the Ministry of Education in June 2011 and officially began enrolling students in August 2012. It is jointly managed by Academia Sinica and seven medical universities nationwide (including National Taiwan University and Kaohsiung Medical University in the 100th academic year; National Yang-Ming University, Taipei Medical University, China Medical University in the 101st academic year; and Tzu Chi University and National Defense Medical Center in the 103rd academic year). The program operates in the same manner across all seven universities, with both the medical universities and Academia Sinica appointing a joint chief convenor. An "Executive Committee" is established under which there are three subcommittees: "Admissions Committee," "Academic Affairs Committee," and "Student Affairs Committee," with members from both institutions serving on these committees. Advisory committee members are appointed as needed. The program also includes full-time faculty, joint appointments of internal and external scholars, several Academia Sinica academicians, distinguished professors, and guest professors with practical experience in the biotech industry to participate in teaching and guiding students.Academic Institute